National Psoriasis Foundation
Residents Meeting on psoriasis and psoriatic arthritis

Faculty Biographies

Alan Menter, M.D. (Co-Chairman)

Alan Menter, M.D. (Co-Chairman)Dr. Alan Menter was born in England and is a graduate of the Medical School of the University of Witwatersrand, South Africa. He completed his dermatology residency at Pretoria General Hospital at the University of Pretoria and two fellowships in London at Guy's Hospital and St. John's Hospital for Diseases of the Skin.

A fellowship with the University of Texas Southwestern Medical Center in Dallas brought Menter to the United States. Since then, he has held several positions within the University of Texas and Baylor University Dallas systems. In 1992, he was appointed chairman of the Division of Dermatology at Baylor University Medical Center and still holds that position. In 2007, he was appointed director of the Baylor Research Center and in 2010, Program Director of the newly formed Dermatology Residency Program at Baylor University Medical Center.

Committed to patients

Dr. Menter has a long-held interest in psoriasis and psoriatic disease research. In 1994, he co-authored the first gene discovery for psoriasis, published in Science in 1994. His research on psoriasis has examined everything from ultraviolet phototherapy to biologic therapy to the mapping of genetic patterns to predict if a person is at risk of developing psoriasis to pharmacogenomics.

In August 2004, Dr. Menter helped found the International Psoriasis Council to raise awareness of psoriasis as a serious autoimmune disease that can significantly impact quality of life. His clinical practice includes more than 1,600 patients on systemic and biologic therapy.

Dedicated to research

Dr. Menter held the position of clinical director of the National Psoriasis Foundation Gene Bank from 1996 to 2002. His resume lists some 300+ articles, four books and 19 book chapters. He serves as a member of the editorial board for several medical journals, including the Journal of Clinical Dermatology and Clinical and Experimental Dermatology. He is chairman of research for dermatology at Baylor Research Institute, as well as clinical professor of dermatology at the University of Texas Southwestern Medical School in Dallas and professor at Texas A&M Health Science Center, College of Medicine.

Other accomplishments

Dr. Menter has been listed in the Best Doctors in America since 1994 and Who's Who in Medicine and Healthcare since 1996. He also represented the South African National Rugby team, the Springboks, in 1968. In 2013, Dr. Menter received the Lifetime Achievement Award from the National Psoriasis Foundation. In March 2015, he will receive the Dermatology Foundation annual Clark W. Finnerud award at the upcoming AAD meeting in San Francisco.

Abrar Qureshi, M.D., M.P.H. (Co-Chairman)

Abrar Qureshi, M.D., M.P.H. (Co-Chairman)Abrar A. Qureshi, M.D., M.P.H. is the chairman and a professor in the Department of Dermatology at the Warren Alpert Medical School of Brown University. He is the Dermatologist-in-Chief at Rhode Island Hospital, The Miriam Hospital and Hasbro Children's Hospital in Providence, Rhode Island as well as the Executive Chief of Dermatology at Women and Infants Hospital, Memorial Hospital of Rhode Island and Butler Hospital. He is also an Associate Epidemiologist at the Channing Laboratory at Brigham and Women's Hospital in Boston, Massachusetts.

Prior to joining the ranks at Alpert Medical School, Dr. Qureshi received his medical degree from Aga Khan University in Karachi, Pakistan, and his Master of Public Health degree in Clinical Effectiveness from the Harvard School of Public Health. He completed his internship in internal medicine at Beth Israel Deaconess Medical Center and his residency in dermatology in the Combined Harvard Residency Training Program and a research fellowship at Massachusetts General Hospital, all in Boston. At Brigham and Women's Hospital and the Dana-Farber Cancer Institute, Qureshi served as associate physician in the Department of Dermatology. He also has held academic appointments at Brigham AND Women's Hospital, Massachusetts General Hospital and the Boston Veterans Administration hospital.

He has received numerous awards, among them several mentorship awards from the Medical Dermatology Society and the Outstanding Service Award and Diversity Mentorship Award from the American Academy of Dermatology.

He is a member of numerous professional organizations, including the Society for Investigative Dermatology, the Society for Epidemiology Research, the American Dermato-Epidemiology Network, the American Association for Cancer Research and the North American Rheumatic Dermatologists.

Dr. Qureshi's major effort is in the clinical and molecular epidemiology of psoriasis and psoriatic arthritis. His research interests are translational, bridging epidemiology and outcomes research with genomics to answer important diagnostic and therapeutic questions. He has published extensively in the area of risk factors for psoriasis and co-morbidities associated with psoriasis and psoriatic arthritis in large prospective US-based studies. His group developed the Psoriasis Screening Brigham-Scalp, Nails, Inverse psoriasis and Palmar-plantar severity Index (B-SNIPI), tools that have been used in large national and international studies.

On a clinical front, in 2003 he co-founded the Center for Skin and Related Musculoskeletal Diseases Clinic in collaboration with the Division of Allergy, Immunology and Rheumatology at Brigham and Women's Hospital and built the first Dermatology-Rheumatology Fellowship that has to-date trained six fellows (two rheumatologists and four dermatologists). He is currently building a new Dermatology-Rheumatology Center at Rhode Island Hospital. Working closely with his rheumatology colleagues, caring for some of the sickest patients with psoriasis and psoriatic arthritis, has been an inspiration for his research endeavors.

Colby Evans, M.D.

Colby Evans, M.D.Colby Evans, M.D. aims to make a difference in the lives of his patients by providing the highest quality care in a comfortable environment. He is Board Certified by the American Board of Dermatology.

A native Texan, Dr. Evans completed his medical degree and residency in dermatology at the University of Texas Southwestern Medical Center in Dallas. Dr. Evans furthered his study with a Clinical Fellowship at the St. John's Institute of Dermatology, an internationally acclaimed institution in London. He holds an undergraduate degree from Wesleyan University, where he graduated Phi Beta Kappa with high honors in chemistry.

Dr. Evans has been published in multiple peer-reviewed journals, including the New England Journal of Medicine and the Journal of the American Academy of Dermatology. He lectures at national medical conferences and has a particular interest in the treatment of skin cancer and psoriasis. He also co-authored and published a medical textbook on geriatric dermatology, Skin Diseases in the Elderly, which has since been translated into multiple languages.

Dr. Evans is a Fellow of the American Academy of Dermatology. He is also a member of the National Psoriasis Foundation, American Medical Association, the Texas Medical Association, and the Travis County Medical Society.

Dr. Evans is honored to be the Chairman of the Board of Directors of the National Psoriasis Foundation, on which he has served since 2010. Dr. Evans volunteers with a free local clinic in Austin and as a faculty member for residency teaching at Brackenridge Hospital. He has served on several volunteer committees with the American Academy of Dermatology, including the Diversity Taskforce, Workforce Taskforce, and Carrier Policy and Medical Liability Taskforce. Dr. Evans was also the 2009 President of the Austin Dermatology Society.

Dr. Evans is currently the Psoriasis Expert for Health and is frequently referenced as an authority on skin disease in local and national publications.

Kenneth Gordon, M.D.

Kenneth Gordon, M.D.Kenneth Gordon, M.D. is a professor of dermatology at Northwestern University‘s Feinberg School of Medicine. Dr. Gordon is also the associate director of the Center for Clinical Research at the Northwestern University Center for Clinical and Translational Science and is part of the Northwestern CTSA grant. He was educated at Amherst College and the Columbia University College of Physicians and Surgeons and trained in internal medicine at the Beth Israel Hospital/Harvard program and in dermatology at Northwestern University. He trained in basic science immunology as a postdoctoral fellow in the lab of Steven Miller, Ph.D. at Northwestern. Dr. Gordon was awarded a Dermatology Foundation Career Development for basic science research in autoimmunity.

Dr. Gordon's research interest is primarily in immunological and clinical aspects of psoriasis and other inflammatory skin diseases. He has conducted well over 100 clinical trials in psoriasis and other diseases and has been published in journals including the New England Journal of Medicine, Journal of the American Medical Association, and The Lancet along with co-editing two textbooks on psoriasis and psoriatic arthritis. Clinically, he helped establish the first multi-specialty clinic in psoriasis and psoriatic arthritis.

Amy Paller, M.D.

Amy Paller, M.D.Amy Paller, M.S., M.D. is the Walter J. Hamlin Chair and Professor of Dermatology, Professor of Pediatrics, and Principal Investigator of the National Institutes of Health-funded Skin Disease Research Center at Northwestern University's Feinberg School of Medicine. She received her undergraduate and graduate degrees from Brown University and her medical degree from Stanford University. Dr. Paller completed residency training in both pediatrics and dermatology at Northwestern University and her postdoctoral research fellowship at the University of North Carolina. She served as Chief of Pediatric Dermatology at Northwestern's Lurie Children's Hospital and currently is chairwoman of Northwestern's Department of Dermatology.

Dr. Paller has served on the Board of the American Academy of Dermatology and American Dermatological Association, and as president and board member of the Society for Pediatric Dermatology, the Society for Investigative Dermatology, the Women's Dermatologic Society, International Eczema Council, and the Chicago Dermatological Society.

An author of more than 400 publications, Dr. Paller is an NIH-funded laboratory-based and clinical investigator. Her clinical interests focus on genodermatoses and pediatric cutaneous immune-mediated disorders. Her laboratory focuses on sphingolipids and lipid raft signaling, diabetic wound healing, and topical gene therapy using nanotechnology, and she serves on the NIH's National Institute of Arthritis and Musculoskeletal and Skin Diseases council.

Dr. Paller directs the Pediatric Dermatology Clinical Trials Unit at Northwestern and has been the lead investigator on several landmark trials in pediatric skin disease. She is co-author or co-editor of leading textbooks of dermatology (Fitzpatrick's Dermatology in General Medicine, Pediatric Dermatology, and Hurwitz's Clinical Pediatric Dermatology) and Associate Editor of the Journal of Investigative Dermatology, among other journals. Dr. Paller co-chairs the Pediatric Dermatology Research Alliance (PeDRA), chairs the American Academy of Dermatology's Patient Advocacy Task Force, is Vice President of the International Society for Atopic Dermatitis, and is Vice Chair of the Dermatology Residency Review Council. She is a board member of several national patient support organizations.

Keep in touch. Stay informed.